Data-driven analysis and druggability assessment methods to accelerate the identification of novel cancer targets
Over the past few decades, drug discovery has greatly improved the outcomes for patients, but several challenges continue to hinder the rapid development of novel drugs. Addressing unmet clinical needs requires the pursuit of drug targets that have a higher likelihood to lead to the development of s...
Main Authors: | G. Beis, A.P. Serafeim, I. Papasotiriou |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-01-01
|
Series: | Computational and Structural Biotechnology Journal |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2001037022005360 |
Similar Items
-
In silico Druggability Assessment of the NUDIX Hydrolase Protein Family as a Workflow for Target Prioritization
by: Maurice Michel, et al.
Published: (2020-05-01) -
Plectasin: from evolution to truncation, expression, and better druggability
by: Xuan Li, et al.
Published: (2023-12-01) -
The druggable genome: Twenty years later
by: Chris J. Radoux, et al.
Published: (2022-09-01) -
Sequence-Derived Markers of Drug Targets and Potentially Druggable Human Proteins
by: Sina Ghadermarzi, et al.
Published: (2019-11-01) -
In Silico Methods for Identification of Potential Active Sites of Therapeutic Targets
by: Jianbo Liao, et al.
Published: (2022-10-01)